Notable Labs, Ltd.
NTBLDelisted Mar 5, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001603207
Notable Labs, Ltd. was delisted on Mar 5, 2025; its insiders filed their last Form 4 on May 10, 2024; 16 institutions reported holding it in 13F filings for Q3 2024, worth $197.6K in total; no superinvestor held it.
13F holders, Q4 2024
Institutional positions in Notable Labs, Ltd. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
NTBL is no longer listed, and 13F filings after Q3 2024 list far fewer holders. See Q3 2024
- Institutional holders
- 0
- −15 vs. Q3 2024
- Shares held
- 0
- −256.1K (−100.0%) vs. Q3 2024
- Total value
- $0
- −$109.7K (−100.0%) vs. Q3 2024
- New holders
- 0
- 0 more added
- Sold out
- 15
- 0 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NTBL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 16 | $197.6K |
| Q2 2024 | 17 | $270.3K |
| Q1 2024 | 14 | $611.8K |
| Q4 2023 | 12 | $550.4K |
| Q3 2023 | 22 | $237.1K |
| Q2 2023 | 17 | $171.8K |
| Q1 2023 | 18 | $137.3K |
| Q4 2022 | 28 | $295.1K |
| Q3 2022 | 26 | $517.6K |
| Q2 2022 | 30 | $11.1M |
| Q1 2022 | 26 | $10.8M |
| Q4 2021 | 26 | $15.2M |
| Q3 2021 | 28 | $10.2M |
| Q2 2021 | 23 | $9.16M |
| Q1 2021 | 25 | $5.39M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Notable Labs, Ltd.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Founders Fund V Management, LLC | 0 | $0 | 0.00% | −117,924−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −36,002−100.0% | Sold out |
| Oppenheimer & Co Inc | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −22,003−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −19,539−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −15,274−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −2,199−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −1,272−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −417−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −229−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −115−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −44−100.0% | Sold out |
| Harel Insurance Investments & Financial Services Ltd. | 0 | $0 | 0.00% | −314−100.0% | Sold out |
| Industry Ventures, L.L.C. | – | – | – | – | Not filed |